Mirati Therapeutics reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agios Pharmaceuticals AGIO:US $ 1.22M 0.7M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 36522M 332M
Astellas Pharma 4503:JP Y 318105M 37255M
AstraZeneca AZN:LN 2425311.81M 57309.55M
Bayer BAYN:GR € 44634M 2087M
Biocryst Pharmaceuticals BCRX:US $ 622.18M 17.72M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Eisai 4523:JP Y 94902M 9M
Eli Lilly And LLY:US $ 16813.8M 305M
GlaxoSmithKline GSK:LN 2211100M 1121700M
IONIS PHARMACEUT IONS:US $ 1253.13M 1M
Moderna Inc MRNA:US 762M 44M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 31031M 244M
Puma Biotechnology PBYI:US $ 97.68M 0.3M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Takeda 4502:JP Y 4602254M 256843M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
YTE INCY:US $ 34.19M 0.01M